High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
467.24M
+6.72%
0.231
+43.3%
473.15M
+5.69%
0.234
+1.89%
483.24M
+5.4%
0.244
-155.45%
Estimates Revision
The market is revising Upward the revenue expectations for Healthcare Services Group, Inc. (HCSG) for FY2025, with the revenue forecasts being adjusted by 0.33% over the past three months. During the same period, the stock price has changed by 18.70%.
Revenue Estimates for FY2025
Revise Upward
+0.33%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-5.34%
In Past 3 Month
Stock Price
Go Up
+18.70%
In Past 3 Month
4 Analyst Rating
Wall Street analysts forecast HCSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCSG is 22.00 USD with a low forecast of 20.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 18.790
Low
20.00
Averages
22.00
High
24.00
Current: 18.790
Low
20.00
Averages
22.00
High
24.00
BMO Capital
Market Perform
initiated
$20
2025-11-12
Reason
BMO Capital
Price Target
$20
2025-11-12
initiated
Market Perform
Reason
BMO Capital initiated coverage of Healthcare Services with a Market Perform rating and $20 price target. The firm believes the company's healthcare end market has reached a turning point following multiple years of depressed occupancy rates. However, the shares are fully valued at current levels, the analyst tells investors in a research note.
UBS
Buy
maintain
$20 -> $22
2025-10-28
Reason
UBS
Price Target
$20 -> $22
2025-10-28
maintain
Buy
Reason
UBS raised the firm's price target on Healthcare Services to $22 from $20 and keeps a Buy rating on the shares.
Benchmark
Buy
maintain
$19 -> $24
2025-10-23
Reason
Benchmark
Price Target
$19 -> $24
2025-10-23
maintain
Buy
Reason
Benchmark raised the firm's price target on Healthcare Services to $24 from $19 and keeps a Buy rating on the shares following what the firm calls "an impressive top-to-bottom beat" in Q3. Cash is building again, with a focus on accretive tuck-in deals likely in the Education segment, the analyst tells investors.
Macquarie
Neutral -> Outperform
upgrade
$15 -> $16
2025-07-28
Reason
Macquarie
Price Target
$15 -> $16
2025-07-28
upgrade
Neutral -> Outperform
Reason
Macquarie upgraded Healthcare Services to Outperform from Neutral with a price target of $16, up from $15. The firm sees upside from stable industry fundamentals, growth momentum, and enhanced capital return. Macquarie also believes the accelerating growth trend is sustainable as the company executed well on sales and retentions despite noise around Genesis.
Baird
Neutral
maintain
$13 -> $15
2025-07-24
Reason
Baird
Price Target
$13 -> $15
2025-07-24
maintain
Neutral
Reason
Baird raised the firm's price target on Healthcare Services to $15 from $13 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results and noted the recent Big Beautiful Bill impact will take some time.
UBS
AJ Rice
Neutral -> Buy
upgrade
$12 -> $15
2025-04-24
Reason
UBS
AJ Rice
Price Target
$12 -> $15
2025-04-24
upgrade
Neutral -> Buy
Reason
UBS analyst AJ Rice upgraded Healthcare Services to Buy from Neutral with a price target of $15, up from $12. The firm believes the company will see an acceleration in revenue growth to 5.7% in 2025 as it benefits from an improving nursing home industry, strong retention, new customer additions, and cross-selling opportunities. Nursing homes represent the majority of Healthcare Services' overall business and is an industry that is recovering from a challenged environment during the pandemic, the analyst tells investors in a research note. UBS says the company's "discounted valuation" offers an attractive entry point.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Healthcare Services Group Inc (HCSG.O) is 19.62, compared to its 5-year average forward P/E of 21.71. For a more detailed relative valuation and DCF analysis to assess Healthcare Services Group Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
21.71
Current PE
19.62
Overvalued PE
30.53
Undervalued PE
12.90
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
11.61
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
15.91
Undervalued EV/EBITDA
7.30
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.70
Current PS
0.00
Overvalued PS
0.99
Undervalued PS
0.40
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 1453.5% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 1453.5% over the last month.
Sold
Bought
HCSG News & Events
Events Timeline
(ET)
2025-10-22
07:03:32
Healthcare Services announces Q3 earnings per share of 59 cents, surpassing consensus estimate of 20 cents.
2025-07-23 (ET)
2025-07-23
07:14:44
Healthcare Services announces $50M share repurchase plan
2025-07-23
07:13:18
Healthcare Services reports Q2 EPS (44c), consensus 20c
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/benzinga.png)
Preview
4.0
11-13BenzingaBMO Capital Begins Coverage of Healthcare Services Group with Market Perform Rating and Sets Price Target at $20
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/afe330897b16c555ae3c9adc6511222cd70b0257f019a104c5f6ef535d0805e1.jpg)
Preview
6.5
11-06NASDAQ.COMProjected Target Price for JSMD Analyst: $92
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/c380ef83f03720045524a796dc765001ac52bd0c5a135812fafda5f0b018b4bb.jpg)
Preview
4.0
10-23NASDAQ.COMHealthcare Services Group Achieves Analyst Price Target
Sign Up For More News
People Also Watch
FAQ
What is Healthcare Services Group Inc (HCSG) stock price today?
What is Healthcare Services Group Inc (HCSG)'s business?
What is the price predicton of HCSG Stock?
What is Healthcare Services Group Inc (HCSG)'s revenue for the last quarter?
What is Healthcare Services Group Inc (HCSG)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Healthcare Services Group Inc (HCSG)'s fundamentals?
How many employees does Healthcare Services Group Inc (HCSG). have?